会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明授权
    • Memory with word-line driver circuit having leakage prevention transistor
    • 具有防漏晶体管的字线驱动电路的存储器
    • US07577054B2
    • 2009-08-18
    • US11979237
    • 2007-10-31
    • Toshikazu Nakamura
    • Toshikazu Nakamura
    • G11C8/00
    • G11C8/08G11C11/4085G11C11/4087G11C29/02G11C29/021G11C29/028G11C2029/1202
    • In a semiconductor memory having a plurality of word lines and bit lines and memory cells arranged at the positions of intersection thereof, a word driver circuit that drives the word line has a drive PMOS transistor and drive NMOS transistor which are connected in series between a first node and a second node and each of which has a gate connected to a third node, the word line being connected to a connection node of the two transistors. A first voltage or a second voltage lower than the first voltage is then applied to the third node, and the first voltage or second voltage is applied to the first node. In addition, between the third node and the gate of the drive PMOS transistor, there is provided a leakage prevention NMOS transistor having a gate applied with the first voltage or a voltage in the vicinity thereof.
    • 在具有布置在其相交位置处的多个字线和位线和存储单元的半导体存储器中,驱动字线的字驱动电路具有驱动PMOS晶体管和驱动NMOS晶体管,其串联连接在第一 节点和第二节点,并且每个节点具有连接到第三节点的栅极,所述字线连接到所述两个晶体管的连接节点。 然后将第一电压或低于第一电压的第二电压施加到第三节点,并且将第一电压或第二电压施加到第一节点。 此外,在驱动PMOS晶体管的第三节点和栅极之间,提供了具有施加有第一电压的栅极或其附近的电压的防漏NMOS晶体管。
    • 17. 发明申请
    • Hgf production accelerator containing heparin-like oligosaccharide
    • 含有肝素寡糖的Hgf生产促进剂
    • US20060293275A1
    • 2006-12-28
    • US10565301
    • 2005-03-28
    • Toshikazu NakamuraKunio MatsumotoKazuhiro Fukuta
    • Toshikazu NakamuraKunio MatsumotoKazuhiro Fukuta
    • A61K31/727
    • C08B37/0075A61K31/7016A61K31/702A61K31/715C07H11/00C08B37/0078C08L5/10C12P19/04
    • The present invention aims to provide an agent for promoting HGF production comprising, as an effective ingredient, a disaccharide comprised of an uronic acid residue (wherein an uronic acid means an iduronic acid or a glucuronic acid, and has the same meaning hereinafter) and a glucosamine residue that are connected by α1,4-glycosidic linkage or β1,4-glycosidic linkage, or an oligosaccharide of tri- to hexadeca-saccharides having a structure in which uronic acid residues and glucosamine residues are alternately and repeatedly connected by α1,4-glycosidic linkage or β1,4-glycosidic linkage, wherein at least one hydroxy group of the uronic acid residues and/or the glucosamine residues may be sulfated, alkylated, acylated or aminated, and/or the amino group at position 2 of at least one of the glucosamine residue(s) may be sulfated, alkylated or acylated, or a salt thereof. The agent of the present invention for promoting HGF production is useful to promote healing of damaged tissues or organs of a living body.
    • 本发明的目的在于提供一种促进HGF生产的试剂,其包含由糖醛酸残基(其中糖醛酸表示艾杜糖醛酸或葡糖醛酸,并且具有下述相同含义)的二糖作为有效成分,和 通过α1,4-糖苷键或β1,4-糖苷键连接的葡糖胺残基或具有其中糖醛酸残基和葡糖胺残基被α1,44交替并重复连接的结构的三十六碳糖的寡糖 - 糖苷键或β1,4-糖苷键,其中所述糖醛酸残基和/或所述葡糖胺残基的至少一个羟基可以被硫酸化,烷基化,酰化或胺化,和/或至少在第2位的氨基 一种或多种葡糖胺残基可被硫酸化,烷基化或酰化,或其盐。 用于促进HGF产生的本发明的药剂可用于促进活体损伤的组织或器官的愈合。